- Bank of America Corp DE increased its stake in Protara Therapeutics, Inc. by 86.7% during the first quarter, owning 925,918 shares valued at $4,824,000.
- Several other institutional investors and hedge funds also modified their holdings in the company, which currently has a market capitalization of $225.76 million.
- Protara Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies for virus-driven cancers, with PTX-35 as its lead candidate.
